期刊
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
卷 65, 期 10, 页码 1316-1320出版社
WILEY
DOI: 10.1111/dmcn.15574
关键词
-
Placebo responses are frequently observed in research studies and clinical contexts, yet there is limited knowledge about the placebo effect among children with neurodevelopmental disorders. In this review, the authors discuss the placebo effect in autism spectrum disorder (ASD) and how it can be influenced by caregivers or clinicians indirectly shaping patient outcomes. Understanding placebo effects in ASD may help differentiate genuine treatment effects from contextual factors in clinical trials and improve research designs and treatments for ASD symptoms. Furthermore, deeper knowledge about placebo and nocebo effects may optimize care delivery for individuals with ASD in the future.
Placebo responses are frequently observed in research studies and clinical contexts, yet there is limited knowledge about the placebo effect among children with neurodevelopmental disorders. Here, we review the placebo effect in autism spectrum disorder (ASD). Placebo responses are widely evident in ASD clinical trials and could partly operate via so-called placebo-by-proxy, whereby caregivers or clinicians indirectly shape patient outcomes. Understanding the role of placebo effects in ASD may help discern genuine treatment effects from contextual factors in clinical trials. The much less studied nocebo effect, or negative placebo, might contribute to the experience of side effects in ASD treatments but empirical data is missing. Better knowledge about placebo and nocebo mechanisms may contribute to the development of more effective research designs, such as three-armed designs that account for natural history, and improved treatments for ASD symptoms. At a clinical level, deeper knowledge about placebo and nocebo effects may optimize the delivery of care for individuals with ASD in the future.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据